Surveillance after curative resection of colorectal cancer

Clinics in Colon and Rectal Surgery

Volumn 22, Issue 4, 2009, Pages 242-250

  Scheer, Adena ^a   Auer, Rebecca Ann C ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Colorectal neoplasm; colorectal surgery; postoperative surveillance

Indexed keywords

EID: 78049322169     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0029-1242464     Document Type: Article

References (49)

1. Bhm B, Schwenk W, Hucke H P., Stock W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 1993 36 (3) 280-286
2. Mkel J T., Laitinen S O., Kairaluoma M I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995 130 (10) 1062-1067
3. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg K G. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995 38 (6) 619-626
4. Kjeldsen B J., Kronborg O, Fenger C, Jrgensen O D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997 84 (5) 666-669
5. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998 41 (9) 1127-1133
6. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998 114 (1) 7-14 (Pubitemid 28020948)
7. Secco G B., Fardelli R, Gianquinto D et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002 28 (4) 418-423
8. Grossmann E M., Johnson F E., Virgo K S., Longo W E., Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol 2004 13 (2-3) 119-124
9. Rodrguez-Moranta F, Sal J, Arcusa A et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006 24 (3) 386-393
10. Tjandra J J., Chan M K. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 2007 50 (11) 1783-1799
11. Jeffery M, Hickey B E., Hider P N. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007 (1) CD002200
12. Figueredo A, Rumble R B., Maroun J et al, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003 3 26
13. Renehan A G., Egger M, Saunders M P., O'Dwyer S T. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002 324 (7341) 813
14. Renehan A G., Egger M, Saunders M P., O'Dwyer S T. Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis. Br J Cancer 2005 92 (3) 430-433
15. Renehan A G., O'Dwyer S T., Whynes D K. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004 328 (7431) 81
16. Goldberg R M., Fleming T R., Tangen C M. et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998 129 (1) 27-35
17. Bruinvels D J., Stiggelbout A M., Kievit J, van Houwelingen H C., Habbema J D., van de Velde C J. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994 219 (2) 174-182
18. Rosen M, Chan L, Beart R W. Jr, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998 41 (9) 1116-1126
19. Audisio R A., Robertson C. Colorectal cancer follow-up: perspectives for future studies. Eur J Surg Oncol 2000 26 (4) 329-337
20. Edelman M J., Meyers F J., Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997 12 (5) 318-331
21. Desch C E., Benson A B. III, Somerfield M R. et al, American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005 23 (33) 8512-8519
22. Practice NCCN. Guidelines in Oncology. National Comprehensive Cancer Network, 2009. Available at: http://www.nccn.org/professionals/physician-gls/f- guidelines.asp Accessed June 5, 2009
23. Scholefield J H., Steele R J., British Society For Gastroenterology Association of Coloproctology for Great Britain and Ireland. Guidelines for follow up after resection of colorectal cancer. Gut 2002 51 (Suppl 5) V3-V5
24. Van Cutsem E J., Oliveira J, ESMO Guidelines Working Group. Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2008 19 (Suppl 2) ii29-ii30
25. Galandiuk S, Wieand H S., Moertel C G. et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992 174 (1) 27-32
26. Stiggelbout A M., de Haes J C., Vree R et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997 75 (6) 914-920
27. Kiebert G M., Welvaart K, Kievit J. Psychological effects of routine follow up on cancer patients after surgery. Eur J Surg 1993 159 (11-12) 601-607
28. Mayer R J., Garnick M B., Steele G D. Jr, Zamcheck N. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 1978 42 (3, Suppl) 1428-1433
29. Glover C, Douse P, Kane P et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002 45 (4) 476-484
30. Moertel C G., Fleming T R., Macdonald J S., Haller D G., Laurie J A., Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993 270 (8) 943-947
31. Goldstein M J., Mitchell E P. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005 23 (4) 338-351
32. Arriola E, Navarro M, Pars D et al. Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer. Dis Colon Rectum 2006 49 (4) 478-484
33. Chau I, Allen M J., Cunningham D et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004 22 (8) 1420-1429
34. Winawer S J., Zauber A G., O'Brien M J. et al, The National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993 328 (13) 901-906
35. Griffin M R., Bergstralh E J., Coffey R J., Beart R W. Jr, Melton L J. III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987 60 (9) 2318-2324
36. Enblad P, Adami H O., Glimelius B, Krusemo U, Phlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 1990 65 (9) 2091-2100
37. Kjeldsen B J., Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999 34 (5) 509-515
38. Borie F, Combescure C, Daurs J P., Trtarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg 2004 28 (6) 563-569
39. Spratlin J L., Hui D, Hanson J, Butts C, Au H J. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer. Clin Colorectal Cancer 2008 7 (2) 118-125
40. Cheung W Y., Pond G R., Rother M et al. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer. Clin Colorectal Cancer 2008 7 (3) 191-196
41. Grossmann I, de Bock G H., van de Velde C J., Kievit J, Wiggers T. Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. Colorectal Dis 2007 9 (9) 787-792
42. Giordano P, Efron J, Vernava A M. III, Weiss E G., Nogueras J J., Wexner S D. Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 2006 10 (3) 199-207
43. Cardella J, Coburn N G., Gagliardi A et al. Compliance, attitudes and barriers to post-operative colorectal cancer follow-up. J Eval Clin Pract 2008 14 (3) 407-415
44. Cheah L P., Hemingway D M. Improving colorectal cancer follow-up: the dedicated single-visit colorectal cancer follow-up clinic. Ann R Coll Surg Engl 2002 84 (4) 260-262
45. Renehan A G., Wille-Jrgensen P. Towards a more prescriptive follow-up regimen for colorectal cancer. Colorectal Dis 2006 8 (8) 623-625
46. Fernandez F G., Drebin J A., Linehan D C., Dehdashti F, Siegel B A., Strasberg S M. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004 240 (3) 438-447 discussion 447-450
47. Fong Y, Saldinger P F., Akhurst T et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999 178 (4) 282-287
48. Shen Y Y., Liang J A., Chen Y K., Tsai C Y., Kao C H. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Hepatogastroenterology 2006 53 (69) 348-350
49. Flanagan F L., Dehdashti F, Ogunbiyi O A., Kodner I J., Siegel B A. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998 227 (3) 319-323